First-in-class Dual HIF Inhibitors Eliminate Multiple Tumor Types in Mice when Combined with Immunotherapy
April 8, 2026
Findings from UMSOP researchers and collaborators point to a promising new strategy for treating a broad range of cancers.
April 8, 2026
Findings from UMSOP researchers and collaborators point to a promising new strategy for treating a broad range of cancers.